Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]
FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]
FBC advises Perrigo, a NYSE and TASE-traded company, in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland.
General Search
Practice Area
Attorney
Date
Publication Type